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Abstract: Cell death with morphological and molecular features of apoptosis has been 
detected in osteoarthritic (OA) cartilage, which suggests a key role for chondrocyte 
death/survival in the pathogenesis of OA. Identification of biomarkers of chondrocyte 
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apoptosis may facilitate the development of novel therapies that may eliminate the cause 
or, at least, slow down the degenerative processes in OA. The aim of this review was to 
explore the molecular markers and signals that induce chondrocyte apoptosis in OA. A 
literature search was conducted in PubMed, Scopus, Web of Science and Google Scholar 
using the keywords chondrocyte death, apoptosis, osteoarthritis, autophagy and biomarker. 
Several molecules considered to be markers of chondrocyte apoptosis will be discussed in 
this brief review. Molecular markers and signalling pathways associated with chondroycte 
apoptosis may turn out to be therapeutic targets in OA and approaches aimed at 
neutralizing apoptosis-inducing molecules may at least delay the progression of cartilage 
degeneration in OA. 
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1. Introduction 
Articular cartilage is an avascular tissue whose functional properties of mechanical support and 
joint lubrication are dependent on the functional integrity of its extracellular matrix (ECM). Cartilage 
ECM is rich in fibrillar collagens, especially type II, large aggregating proteoglycans and smaller 
hydrophilic macromolecules that confer lubricative and swelling properties to the tissue [1]. Under 
normal physiological conditions chondrocytes maintain a delicate equilibrium between the synthesis 
and degradation of the ECM components, thus regulating the structural and functional integrity of  
cartilage [2]. Cartilage is an avascular tissue with limited regenerative ability. Furthermore, in 
degenerative joint diseases there is evidence of cell death in chondrocytes, with consequent 
repercussions on tissue maintenance and functionality. Apoptotic cell death has been detected in 
osteoarthritic (OA) cartilage; this was associated with matrix degradation and calcification, which 
suggests a role for cell death/survival in OA pathogenesis. In contrast to necrotic cell death, apoptosis 
is programmed, orderly and does not induce inflammation. Apoptosis requires energy and is generally 
important for tissue homeostasis during the life course of an individual [3]. Apoptosis represents a 
form of programmed cell death in which a pre-determined sequence of events leads to the elimination 
of old, unnecessary and unhealthy cells, without releasing harmful substances into the surrounding  
area [4]. Cells that are undergoing apoptosis exhibit a characteristic pattern of morphologic changes, 
including cell shrinkage, condensation, fragmentation of the nucleus and bubbling of the plasma 
membrane, known as “blebbing”, chromatin condensation and nucleosomal fragmentation [5]. The 
crucial function of apoptotic mechanisms in cartilage degeneration and the involvement of apoptosis in 
various conditions associated with OA have been thoroughly explored [6–9]. 
2. Methods 
In this review, we analysed published articles from the most recent literature, providing a balanced 
and comprehensive overview of the most important discoveries in relation to pathogenesis and possible 
biomarkers and target molecules for the treatment of OA. Subsequently the selected articles were  
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divided in “Osteoarthritis”, “Chondrocytes apoptosis in Osteoarthritis”, “Biomarkers of chondrocyte 
degeneration” and “Autophagy”, to structure the review and render it more understandable for 
interested researchers by providing a detailed and schematic overview of the most relevant studies that 
have been done in this field. The literature search and the manuscript writing were done between 
December 2014 and August 2015. The databases used were PubMed, Scopus, Web of Science and 
Google Scholar using appropriate keywords (chondrocyte death, apoptosis, osteoarthritis, autophagy, 
biomarkers). Out of approximately 220 papers (original articles, systematic and meta-analysis 
reviews), 81 were chosen and considered appropriate for this focused review. Other papers, related to 
the chosen keywords, were discarded, as they were considered to be outside the scope of the research. 
The time period chosen for the literature search was from 1998 until 2015. The bibliographic research 
has been divided into four different steps and has followed an inductive reasoning. In the first step, the 
research was focused on papers regarding “osteoarthritis”; in the second step the “Chondrocytes 
apoptosis in Osteoarthritis”; in the third step the “Biomarkers of chondrocyte degeneration” and in the 
fourth step the “Autophagy”. The overall research was focused on both in vitro and in vivo studies, and 
on the analysis of the obtained data. 
3. Chondrocyte Apoptosis in Osteoarthritis 
Apoptosis has been positively correlated with the severity of cartilage destruction and matrix 
depletion in human osteoarthritic tissue specimens [1]. Freshly isolated chondrocytes from human OA 
cartilage exhibited morphological evidence of apoptosis, clear cytoplasmic, cell-surface blebs, altered 
nuclear shape, apoptotic bodies and a parallel loss of nuclear volume. Chondrocytes from normal 
donors did not show any cytoplasmic features of apoptotic cell death. These findings suggest that the 
OA chondrocytes demonstrate differences in predisposition towards apoptosis [4,7]. In general studies 
of cartilage apoptosis several molecules are considered to be potential biomarkers but in the current 
literature only a few of them are discussed in this context. The studies published thus far have used a 
wide range of techniques, such as histology, terminal deoxynucleotidyl trasferase dUTP nick end 
labelling (TUNEL), analysis of caspase-3 expression, enzyme linked immunosorbent assays (ELISA), 
anti-poly (ADPribose) polymerase (anti-PARP), p85 and fluorescence activated cell sorter analysis 
(FACS) to examine the relationship between apoptosis and chondrocytes death in OA. In several 
studies, electron microscopy was used to identify ultrastructural changes attributable to apoptosis in 
chondrocytes within osteoarthritic cartilage [6]. Apoptosis is induced through two main, alternative 
pathways: death receptor-mediated (or extrinsic) and mitochondria-dependent (or intrinsic), both lead 
to the activation of executor caspases [4–7]. Caspases are a group of intracellular cysteine protease 
enzymes that destroy essential cellular proteins, leading to controlled cell death. There are two  
types of caspase enzymes: initiator caspases (caspases 2, 8, 9, and 10), activated through the  
apoptosis-signaling pathways, that activate the effector caspases (caspases 3, 6, and 7), which, in  
an expanding cascade, carry out apoptosis [10–12]. Caspase 3 promotes the typical apoptosis  
features, including DNA fragmentation and cell death in many tissues including cartilage [9–12].  
The intrinsic pathway of apoptosis is regulated by mitochondrial parameters [13–15]. Mitochondrial 
mediated apoptosis may initiate through the release of pro-apoptotic proteins into the cytosol due to 
mitochondrial dysfunction [13–15]. However, mitochondria also contain anti-apoptotic proteins [14]. 
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Mitochondrial pro- and anti-apoptotic proteins belong to the B-cell lymphoma-2 (Bcl-2) family, and 
the balance between them controls apoptosis [14,16]. The anti-apoptotic proteins Bcl-2 and Bcl-XL  
inhibit cytochrome c (cyt-c) release, whereas Bcl-2-associated X protein (Bax), Bcl-2 homologous 
antagonist/killer (Bak), and BH3 interacting domain death agonist (Bid), all pro-apoptotic proteins, 
promote its release from mitochondria. Cyt-c and deoxyadenosine triphosphate (dATP) bind to 
apoptotic protease activating factor (Apaf-1) to form a multimeric complex that recruits and activates 
procaspase 9, that in turn activates caspase 3, resulting in cell apoptosis (Figure 1) [3,17]. The extrinsic 
pathway of apoptosis is activated by pro-apoptotic receptors on the cell surface [18]. 
 
Figure 1. The intrinsic pathway of apoptosis. Bcl-2: B-cell lymphoma-2; Bcl-XL: B-cell 
lymphoma-XL; Bax: Bcl-2-associated X protein; Bak: Bcl-2 homologous antagonist/killer; 
Bid: BH3 interacting domain death agonist; dATP: deoxyadenosine triphosphate; Apaf-1: 
apoptotic protease activating factor. 
4. Biomarkers of Chondrocyte Degeneration 
The molecular signals involved in the cartilage degeneration that is typical of OA are numerous and 
act via specific pathways that are shared with other molecules. Current OA biomarker research has 
focused on investigating the molecular markers involved in the degeneration of cartilage in OA, in 
order to develop new diagnostic and prognostic assays and facilitate the development of novel disease 
modifying therapies. In this brief review we report on molecular biomarkers of chondrocyte apoptosis 
in order to expand the knowledge that is currently available in this topic and provide a fresh 
perspective for apoptosis and biomarker researchers. Several studies have demonstrated that nitric 
oxide (NO) plays a role in chondrocyte apoptosis [19,20]. NO is thought to operate through a 
mitochondria-dependent mechanism, enhancing the expression of pro-inflammatory cytokines 
involved in the breakdown of cartilage ECM [21–24]. Chemical NO donors such as sodium 
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nitroprusside (SNP) induce cell death in cultured human chondrocytes [24]. Incubation of human 
articular chondrocytes with SNP has been shown to increase caspase-3 and caspase-7 gene expression 
and downregulate Bcl-2 mRNA levels, which is characteristic of apoptosis [21–24]. SNP can  
induce apoptosis of human chondrocytes through cytoskeletal remodeling, mitogen-activated  
protein kinase kinase kinase-1/c-Jun N-terminal kinase (MEKK1/JNK) activation, Bax translocation, 
mitochondrial dysfunction and sequential caspase activation (caspase-9, -3 and -6), leading to DNA 
fragmentation [20,21]. NO may be blocked by reactive oxygen species (ROS), and the balance 
between intracellular NO and ROS seems to determine if chondrocytes die through apoptosis or 
necrosis; indeed when the concentration of ROS is low, apoptosis occurs in the presence of NO.  
In contrast, high concentrations of ROS promote necrosis [25]. Incubation with NO alone does not 
induce apoptotic cell death in chondrocytes [25,26]. However, many reports indicate that NO, as a 
catabolic factor in OA, can induce cell death [25,26]. Another study showed that apoptotic bodies 
isolated from NO-treated chondrocytes contain alkaline phosphatase, nucleoside triphosphate (NTP) 
pyrophosphohydrolase activities and can precipitate calcium [27,28], and it is well known that calcium 
signalling is involved in almost cellular functions including metabolism, proliferation, differentiation, 
and also apoptosis [20,29]. NO was shown to cause cell death and induce the tumour suppressor 
protein p53 via p38 mitogen-activated protein kinase (MAPK) and nuclear factor κB (NF-κB) [21,30]. 
In addition to p53, c-myc may also regulate chondrocyte death in OA. In lesions of arthritic  
cartilage, in situ nick-end labeling (ISNEL), which identifies apoptotic cells, is associated with  
the expression of p53 and c-myc [31], and in a canine model of OA, high levels of c-myc  
were shown in cartilage erosions [32]. Another important biomarker of chondrocyte apoptosis is  
the death receptor Fas that induces cell death following ligation with Fas ligand (FasL) [33].  
Fas-mediated chondrocyte loss may contribute to cartilage degradation in OA and rheumatoid arthritis  
(RA) [20,27,28]. Fas ligation by FasL is followed by recruitment of Fas-associated death domain 
(FADD) and subsequently of caspase 8 activation, which can be inhibited by the anti-apoptotic 
molecule FLICE inhibitory protein (Flip). Caspase 8 induces apoptosis by directly activating caspase 3 
or by cleaving Bid, resulting in mitochondrial dysfunction and subsequent release of cyt-c and 
activation of caspases 9 and 3 (Figure 2) [3,6]. Poly (ADP-ribose) polymerase 1 (PARP-1) is a nuclear 
DNA repair enzyme that is implicated in DNA repair and maintenance of genomic integrity. In 
apoptosis, PARP-1 is cleaved and inactivated by caspase-3, resulting in the formation of an N-terminal 
fragment containing most of the DNA binding domain and a C-terminal fragment containing the 
catalytic domain [10–12]. Thus, the presence of C-terminal (89 kDa) PARP-1 fragment is considered 
an important biomarker of apoptosis [10–12,34]. Authors investigated the histological aspects of the 
growth plate after injury and the relative caspase-3 expression by immunohistochemistry and 
histomorphometry; moreover western blot analysis was carried out to quantify the expression of 
caspase-3 and cleaved PARP-1. They concluded that caspase-3 and cleaved PARP-1 expression 
significantly increases in growth plate chondrocytes with a time-course progression [9,10,35]. A  
recent study showed that Toll-like receptors 1/2 (TLR1/2) were expressed in degenerated chondrocytes 
in OA, and may react to cartilage matrix/chondrocyte-derived danger signals or degradation  
products. This leads to synthesis of pro-inflammatory cytokines, which stimulate further TLRs and 
cytokine expression, establishing a vicious circle. They also demonstrated that tumour necrosis  
factor-α (TNF-α) treatment increased TLR1 and TLR2 mRNA expression [36–38]. If TNF-α mediates 
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chondrocyte death is under observation. Data in literature showed that TNF-α stimulation of 
chondrocytes led to a small increase in the number of TUNEL- or ISNEL-positive cells [21,39]. 
Moreover, DNA fragmentation in response to TNF-α was detected with a sensitive ELISA based 
technique when the chondrocytes were simultaneously stimulated with proteasome inhibitors [40]. 
Therefore, TNF-α alone may have no effect on apoptosis [21]. However, TNF-α in combination  
with actinomycin-D or Ro 31–8220 induces an increase in caspase-1 and -8 mRNA and protein  
levels [41,42]. Instead, the transforming growth factor beta (TGF-β) in articular cartilage can work via 
two pathways, the ALK5/Smad2/3P and the ALK1/Smad1/5/8P route, the first being protective and the 
latter favouring chondrocyte terminal differentiation [43]. Normally TGF-β has chondroprotective 
capabilities, but under specific conditions it should determine OA like changes in healthy articular 
cartilage [44,45], shifting the molecular pathway from ALK5/Smad2/3P to ALK1/Smad1/5/8P, 
favouring terminal differentiation of chondrocytes and apoptosis [43,46]. Various inflammatory 
conditions, including arthritis, are characterized by cartilage degradation through ECM destruction that 
should be also mediated by the small calcium-binding S100 proteins [21,47]. The interaction of small 
calcium-bindingA4 (S100A4) with receptor for advanced glycation end products (RAGE) increases 
matrix metalloproteinase (MMP)-13 production in cartilage [47], and upregulates MMP-13 and other 
MMPs in RA derived synovial fibroblasts [48]. S100A4 was reported to bind tumour suppressor 
protein p53 and to regulate its function [49], possibly promoting apoptosis. In OA cartilage 
histological analysis has revealed structural alterations and histochemical results have confirmed the 
presence of matrix calcification and reduction in proteoglycans, which reflects the presence of 
pathological changes. Moreover, these data coincided with an immunohistochemical increase in 
apoptotic cells, when compared to normal cartilage [4,7]. The inflammation process causes stress to 
chondrocytes and induces cell death as a biological defense mechanism; on the other hand, survival of 
new chondrocytes increases in order to maintain cell homeostasis [4,7,50,51]. Our hypothesis is that 
chondrocyte apoptosis could be secondary to cartilage degradation. It is supported by the fact that  
cell-matrix interaction is vital for chondrocyte survivability. Chondrocyte survival is thought to be 
mediated by integrins connecting the ECM components, like collagen, laminin and fibronectin, to 
various intracellular cytoskeletal proteins [6]. Loss of this adhesion may trigger chondrocyte apoptosis. 
It is likely that disruption in chondrocyte-matrix interaction is either due to direct injury to the 
cartilage, causing biochemical changes or loss of ECM (e.g., denaturation of type II collagen, changes 
in fibronectin and other matrix protein expressions) [6]. Moreover, the extent of chondrocyte apoptosis 
is positively correlated with expression of fibronectin, one of the key ECM molecules involved in 
communication between the cartilage cells and surrounding matrix, and up-regulation of expression of 
which is associated with the severity of articular cartilage damage [8]. Decreased expression or 
availability of important ECM macromolecules in cartilage is sufficient to induce chondrocyte 
apoptosis and cause exacerbation of matrix damage [6,8]. It has been observed that TNF-α-stimulation 
can cause dose-dependent depletion of proteoglycans [36]. A chondroprotective agent is the mucinous 
glycoprotein product of the proteoglycan 4 (PRG4) gene, called lubricin [52,53]. Lubricin is 
responsible for the boundary lubrication of articular cartilage [52,53] and other joint parts [54–57]. 
Thanks to its boundary-lubricating properties, lubricin prevents synoviocyte overgrowth, protects 
cartilage surfaces and prevents cartilage wear [58]. Drug therapy with glucocorticoids (GCs) decreases 
the expression of lubricin and increases the expression of caspase-3 in rats, determining increased 
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friction in the joint. Following physical activity the values return to normal levels compared to  
controls [50,59]. Mechanical stimulation is able to stimulate release of lubricin in articular cartilage 
and to inhibit caspase-3 activity, preventing chondrocyte death [50,60]. Nevertheless mechanical 
injury has been demonstrated to induce cell death and cartilage matrix degradation in bovine  
and human cartilage, through the release of ROS and proteoglycans, and the production of  
inflammatory and catabolic factors, such as MMPs, NO, “a disintegrin and metalloprotease with 
thrombospondin type I repeats-5” (ADAMTS-5) and interleukin-1β (IL-1β), [21,61–64]. Moreover, 
western blot analysis revealed that static load-induced chondrocyte apoptosis was accompanied by 
increased phosphorylation of JNK, extracellular signal-regulated kinase 1/2 (ERK1/2), and p38 
mitogen-activated protein kinase (MAPK). So the mitochondrial pathway is involved in mechanical 
stress-induced chondrocyte apoptosis [65]. Glucocorticoids activate the caspase cascade and trigger 
Bax-mediated mitochondrial apoptosis in growth plate chondrocytes, causing growth retardation in 
young mice, indeed dexamethasone was found to increase the pro-apoptotic proteins Bcl-xS, Bad, and 
Bak as well as the proteolysis of Bid [50,60,66]. Syndecan-4 is a transmembrane heparan sulfate 
proteoglycan and its immunostaining is abundant in both human and murine OA cartilage [46,67].  
In vitro studies have identified direct interactions between syndecan-4 and ADAMTS-5, and it is 
claimed that ADAMTS-5 activity, causing aggrecan breakdown in OA [68], is dependent on MMP-3, 
mediating collagen type II breakdown and cartilage erosion, and the latter activity is controlled by 
syndecan-4 [67,69,70]. 
 
Figure 2. The extrinsic pathway of apoptosis. FasL: death-inducing molecule Fas ligand; 
FADD: Fas-associated death domain; Flip: FLICE inhibitory protein; Bid: BH3 interacting 
domain death agonist. 
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5. Autophagy 
Autophagy is a self-degradative process that is important for balancing sources of energy at critical 
times during development and in response to cell stress. Although autophagy is not a type of cell death, 
it is important for cartilage homeostasis. Generally autophagy promotes cell survival by adapting cells 
to stress conditions, but this process has also been considered as a non-apoptotic cell death  
program [71–73]. Although autophagy shares some characteristics with apoptosis, such as absence of 
inflammation during the death process as well as ATP consumption, apoptosis is an essential 
physiological process that plays a critical role in development and tissue homeostasis, whereas 
autophagy means literally, to eat oneself, and in most circumstances, autophagy promotes cell survival 
by adapting cells to stress conditions, but at the same time, this process has also been considered as a 
non-apoptotic cell death program [72]. During autophagy, parts of the cytoplasm and intracellular 
organelles are sequestered within characteristic autophagic vacuoles and are subsequently degraded by 
lysosomes. Recent data support the idea that autophagy can occur in combination with apoptosis in  
OA [21,72], indeed Almonte-Becerril and collaborators demonstrated that in early stages of OA, 
chondrocytes from the superficial zone showed an increased expression of both apoptotic cell death 
and autophagic markers, even if authors suggested that autophagy is activated as an adaptive response 
to sublethal conditions, with the aim to avoid cell death. Afterward, as the degenerative process 
progresses, the conjunctly expression of both death markers in chondrocytes from both the superficial 
and middle zones, can be related with a defect in the reparation response of chondrocytes, due the 
increased activation of death signals, as well as the catabolic mechanisms prevalence. On the other 
hand, in the deep zone, authors evidenced the absence of autophagy and the increased apoptosis, that 
can be associated with the substitution of chondrocytes linked to the abnormal calcification of the 
cartilage present in late stage of OA. Therefore, authors concluded that the functional relationship 
between apoptosis and autophagy during OA pathogenesis is complex in the sense that, in early stages 
of OA, autophagy probably could be activated as an adaptive response that avoids cell death, whereas 
in late stages of OA, this process also could be conjunctly activated with apoptosis as an alternative 
pathway to cellular demise [72]. Further studies are requires to precise and confirm the role of 
autophagic cell death, in the different stages of cartilage breakdown during the experimental OA  
model [21,72]. In induced murine OA, it was shown that decreased expression of the autophagy 
markers correlate with proteoglycan loss and an increase in the levels of the apoptosis marker PARP 
p85 [46,74]. In addition, in OA, autophagy is associated with an increased chondrocyte apoptosis and a 
reduction and loss of Unc-51-like kinase 1 (ULK1), an inducer of autophagy, Beclin1, a regulator of 
autophagy, and microtubule associated protein 1 light chain 3 (LC3), which executes autophagy 
(Figure 3, Table 1) [20,74]. Autophagy can be inhibited by interleukins cleaved by Nod-like receptor 
protein 3 (NLRP3)-dependent caspase-1 [20,75,76]. Moreover several autophagy-inducing agents are 
object of recent researches as protective for OA. Among them, Tougu Xiaotong capsule inhibits 
tidemark replication and cartilage degradation by regulating chondrocyte autophagy and it could be a 
potential therapeutic agent for the reduction of cartilage degradation that occurs in osteoarthritis [77]. 
Manipulation of Hypoxia-inducible factor 1-alpha (HIF-1α) and 2-alpha (HIF-2α) has been suggested 
as a promising approach to the treatment of OA. Indeed the increased HIF-1α and HIF-2α mediate the 
response of chondrocytes to hypoxia. HIF-1α regulates both autophagy and apoptosis, promoting the 
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chondrocyte phenotype, maintaining chondrocyte viability, and supporting metabolic adaptation to a 
hypoxic environment. In contrast HIF-2α induces the expression of catabolic factors in chondrocytes, 
and enhances Fas expression leading to chondrocyte apoptosis and regulates autophagy in maturing 
chondrocytes [78]. Recent studies showed that rapamycin activates autophagy in human chondrocytes 
preventing the development of OA in vitro, while the systemic and/or intra-articular injection of 
rapamycin reduces the severity of experimental osteoarthritis in vivo [79], representing a potential 
therapeutic approach to prevent OA. Also glucosamine modulates and enhances autophagy pathway  
in vitro and in vivo, warranting other studies on the efficacy of glucosamine in OA [80]. 
 
Figure 3. Key features of autophagy. Cytoplasmic and intracellular organelles are 
sequestered within autophagic vacuoles to be degraded by lysosomes. 
Table 1. Key features of different types of cell death. 
Apoptosis Necrosis Autophagy 
Rounding of cells;  
Plasma membrane blebbing;  
Nuclear fragmentation;  
Chromatin condensation;  
Reduction in cellular and nuclear volume;  
Apoptosis body formation;  
Mitochondrial swelling (rare) 
Plasma membrane rupture; 
Mitochondrial and 
cytoplasmic swelling;  
No vesicle formation;  
Moderate chromatin 
condensation 
Accumulation of autophagic 
vacuoles;  
Lack of chromatin 
condensation;  
Late-stage mitochondrial 
swelling 
6. Conclusions 
The diversity of the molecular signals that can induce cell death in chondrocytes in OA lead us to 
hypothesize that future therapeutic approaches should be aimed at neutralizing untimely and excessive 
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apoptosis in articular cartilage. Developing novel biological and pharmaceutical agents that can 
counteract apoptosis and neutralise apoptosis-inducing molecules could potentially delay the 
progression of cartilage degeneration in OA. Identification of target molecules for gene therapy or 
biological or chemical reagent delivery to target sites could help prevent cartilage degeneration. 
Further longer-term in vitro, in vivo and clinical studies are needed to understand the precise role of 
apoptosis in cartilage degeneration mechanisms in OA and other osteoarticular disorders. 
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